Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrodotoxin-sensitive voltage-gated sodium channels (TTX-S VGSCs) are a group of transmembrane proteins that mediate the rapid influx of sodium ions necessary for action potential initiation and propagation in neurons (Catterall, 2000). In the dorsal root ganglion (DRG), this group primarily includes the subtypes Nav1.1, Nav1.2, Nav1.3, Nav1.6, and Nav1.7 (Waxman et al., 1999). These channels are critical for sensory transduction, and their activity determines the excitability of peripheral nociceptors that transmit pain signals to the spinal cord (Dib-Hajj et al., 2013). Nav1.7, in particular, is a highly validated target for pain management, as gain-of-function mutations lead to severe pain disorders like erythromelalgia, while loss-of-function mutations result in congenital insensitivity to pain (Rush et al., 2007). Other subtypes like Nav1.3 are often upregulated following nerve injury, contributing to the development of chronic neuropathic pain states (Theile and Cummins, 2011). Pharmacological agents targeting these channels include traditional non-selective blockers like lidocaine and carbamazepine, as well as newer, subtype-selective inhibitors currently in clinical development (Bennett et al., 2019). The primary therapeutic challenge lies in achieving high selectivity for peripheral TTX-S subtypes over CNS or cardiac isoforms to avoid adverse effects such as dizziness, ataxia, or arrhythmias. These channels represent a critical interface between peripheral stimuli and the perception of pain, making them central to analgesic drug discovery.
Inhibition of sodium ion influx through the channel pore or stabilization of the inactivated state, thereby reducing the frequency and likelihood of action potential firing in sensory neurons.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrodotoxin-sensitive voltage-gated sodium channel (TTX-S Nav) (TTX-S Nav).